Cargando…
Comparative Clinical Value of Pharmacologic Therapies for B-Cell Chronic Lymphocytic Leukemia: An Umbrella Analysis
Several new drugs are progressively improving the life span of patients with B-cell chronic lymphocytic leukemia (CLL). However, the rapidly evolving standard of care precludes robust assessments of the incremental clinical value of further innovative drugs. Therefore, we systematically reviewed com...
Autores principales: | Marchetti, Monia, Rivela, Paolo, Bertassello, Claudia, Canicattì, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999707/ https://www.ncbi.nlm.nih.gov/pubmed/35407474 http://dx.doi.org/10.3390/jcm11071868 |
Ejemplares similares
-
Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice
por: Tavarozzi, Rita, et al.
Publicado: (2023) -
Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence
por: Marchetti, Monia, et al.
Publicado: (2022) -
Quantification of newly produced B and T lymphocytes in untreated chronic lymphocytic leukemia patients
por: Motta, Marina, et al.
Publicado: (2010) -
Highlights: B-chronic lymphocytic leukemia: Current diagnostic characteristics of and treatments for chronic lymphocytic leukemia in Japan
por: Aoki, Sadao
Publicado: (2020) -
Systematic reviews of pharmacological and nonpharmacological treatments for patients with chronic urticaria: An umbrella systematic review
por: Shi, Yunzhou, et al.
Publicado: (2019)